Diabetes: Bayer lands FDA OK to pair with Medtronic's new 'artificial pancreas'

October 21, 2013 by Arezu Sarvestani

Bayer's Contour Next Link blood glucose meter is the 1st U.S.-cleared device that pairs with Medtronic's newly approved 'artificial pancreas', the MiniMed 530G with Enlite diabetes management system.

Diabetes: Bayer lands FDA OK to pair with Medtronic's new 'artificial pancreas'

Bayer (PINK:BAYRY) today announced that it won FDA clearance to pair its Contour Next Link blood glucose meter with Medtronic's (NYSE:MDT) newly approved MiniMed 530G with Enlite, the 1st "artificial pancreas" system for patients with diabetes.

Bayer's meter is the 1st device with the FDA's OK to pair with the new MiniMed system, the 1st U.S.-approved device of its kind to feature threshold suspend automation, the ability to automatically stop halt glucose delivery at a preset level. The Contour Next Link measures blood glucose levels to regulate insulin delivery by MiniMed 530G.

Sign up to get our free newsletters delivered right to your inbox.

Bayer's system can also wirelessly transmit blood glucose test results to Medtronic's insulin devices and communicate via Medtronic's CareLink software, according to a press release.

Comments